Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Lilly becomes first pharma to hit US$ 1 tn valuation; FDA clears Padcev-Keytruda combo for bladder cancer

In Phispers this week, Eli Lilly became the first pharmaceutical company to reach a market valuation of US$ 1 trillion, driven ...

Impressions : 1011

Merck to buy Cidara for US$ 9.2 bn to strengthen infectious disease portfolio; J&J to acquire Halda for US$ 3.05 bn

In this week’s Phispers, Merck struck a US$ 9.2 billion deal to acquire Cidara Therapeutics to strengthen its infectious-...

Impressions : 682

Pfizer seals up to US$ 10 bn deal for Metsera; FDA lifts black box warning on hormone therapies for menopause

In Phispers this week, Pfizer won its high stakes battle with Novo Nordisk for the obesity-focused biotech Metsera. The deal i...

Impressions : 987

Pfizer, Novo escalate bidding war for obesity-drug developer Metsera; Kimberly-Clark to buy Kenvue for US$ 48.7 bn

As we return from our one-week break due to the CPhI Worldwide, we find our double-dose Phispers edition to be filled with se...

Impressions : 958

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Lilly becomes first pharma to hit US$ 1 tn valuation; FDA clears Padcev-Keytruda combo for bladder cancer

Merck to buy Cidara for US$ 9.2 bn to strengthen infectious disease portfolio; J&J to acquire Halda for US$ 3.05 bn

Pfizer seals up to US$ 10 bn deal for Metsera; FDA lifts black box warning on hormone therapies for menopause

Pfizer, Novo escalate bidding war for obesity-drug developer Metsera; Kimberly-Clark to buy Kenvue for US$ 48.7 bn

Otsuka Pharm's Biologics Voyxact Receives Approval in US

Zydus' Generics Verapamil HCl Receives Approval in US

Alembic Pharms' Generics Dapagliflozin Receives Approval in US

Micro's Generics Olmesartan Medoxomil Receives Approval in US

Apotex's Ruxolitinib Receives Approval in US

Inventia Hlthcare Generics Dapagliflozin Receives Approval in US

Alvotech USA's Ustekinumab Receives BLA Approval in US

Aurobindo's Generics Potassium Chloride Receives Approval in US

Xiromed's Generics Clobetasol Propionate Receives Approval in US

Accord BioPharma Ustekinumab Receives BLA Approval in US

FDA Issues Form 483 to North American Custom Laboratories

Wells Pharma of Houston's Receives FDA Warning Letter

Owen Bio's Receives FDA Warning Letter

FDA Issues Form 483 to Fareva Amboise

FDA Issues Form 483 to Immacule Lifesciences

Cdymax Pharma's Receives FDA Warning Letter

Siddha Flower Essences' Receives FDA Warning Letter

RNA Bio Pharma's Receives FDA Warning Letter

RNA Bio/Pharma's Recieves FDA Warning Letter

Cdymax's Receives FDA Warning Letter

Haleon May Rope In Ex-Md Of Castrol India To Head Local Biz

Novo Nordisk Seeks FDA Approval for Higher 7.2mg Wegovy Dose

Innovent's PECONDLE Il-23P19 Antibody Approved By NMPA In China

IPC To Train Small-Scale Pharma & Medtech Firms In Enhancing PV

TG Therapeutics To Attend Evercore Healthcare Conference

Profound Medical To Debut Ai BPH Module, Unveil TULSA-PRO Data

Spero Therapeutics Grants Inducement Under Nasdaq Rule 5635(c)(4)

Hydreight Acquires 5% Stake in Perfect Scripts

Boehringer Ingelheim Appoints New Board Member

Cuprina Holdings Receives Nasdaq Letter On Bid Price Deficiency

Zydus Gets Tentative FDA Nod For Empagliflozin, Linagliptin

Zentiva Earns ESG Transparency Award 2025

Generic HIV Drug Rollout To Take A Hit On Trial Push

Novo Nordisk Cuts Wegovy Prices, Generic Firms Adjust Pricing

FDA Approves SMS Pharma's Reformulated Ranitidine

Pacira Sues WhiteOak, Qilu Pharma Over EXPAREL Patents

Sarepta to Test Elevidys with Immunosuppressive Regimen

Zydus Gets FDA Nod For Verapamil Hydrochloride ER Tablets

Neuland, Lupin, Divi's Lead CDMO Surge Amid U.S. Generics Woes

Marksans Pharma Gets USFDA Nod For Loperamide Tablets

Novo Nordisk Seeks FDA Approval for Higher 7.2mg Wegovy Dose

Innovent's PECONDLE Il-23P19 Antibody Approved By NMPA In China

Spero Therapeutics Grants Inducement Under Nasdaq Rule 5635(c)(4)

Nurexone Biologic Reveals Q3 2025 Financials & Corporate Update

Pasithea Therapeutics Prices $60M Public Stock Offering

Rakovina Therapeutics Extends Debentures With Debentureholder

Abbvie Concludes Loi With Pan-Canadian Pharma Alliance

Kane Biotech Announces Third Quarter 2025 Financial Results

Adicet Bio Discloses Inducement Grant Per Nasdaq LR 5635(C)(4)

Imugene, JW Therapeutics Collaborate Oncarlytics & Carteyva

Dipharma Introduces Method To Detect Nitrosamine formation APIs

Supriya Lifescience Expands Lote Facility With New Module E

HRV Pharma And Metrochem Forge Strategic CDMO Alliance

Antheia links with TAPI to scale biosynthetic drug ingredients

Supply Chain Ties, Bayer Biotech Incubator—Fierce Pharma Asia

Solara's Mangalore facility clears FDA inspection

Celltrion Earmarks $478M To Bolster US Manufacturing Capacity

Successful Approval of CEP Certificate for Lidocaine HCL

Novartis To Set Up Manufacturing Hub In NC, Add 700 Jobs

Import Price Floor On Cards For Critical Pharma Inputs

Ethiopian Team Visits Telangana for Drug Regulation Study

Torrent Pharma Fined Rs 41 Crore Over Alleged Wrong GST Refund

FDA Grants VAI Status to Biocon's Bengaluru Facility

CDSCO Bans High-Risk Solvents in Pediatric Oral Drugs

Glenmark Pharma Gets VAI From FDA For Monroe Facility

CDSCO Panel Calls For Consistent Drug Standard Enforcement

Telangana DCA Enforces CDSCO Mandate For Drug Safety Reporting

Sanofi Caught Up In Tax Fraud Probe Involving Several Companies

Haryana FDA Hosts Summit on Spurious Drugs, NDPS Fight

Abbott Urgently Corrects Freestyle Libre 3 Sensors Over Safety

IPC To Train Small-Scale Pharma & Medtech Firms In Enhancing PV

Profound Medical To Debut Ai BPH Module, Unveil TULSA-PRO Data

Cercare Medical Unveils CBCT Perfusion Tech At RSNA 2025